The SNAI2 gene is associated with a condition known as piebaldism, a rare genetic disorder characterized by the absence of melanocytes in certain areas of the skin and hair, leading to white patches of skin and hair. The SNAI2 gene plays a crucial role in the development and migration of melanocytes, cells responsible for pigment production in the skin and hair. Mutations in the SNAI2 gene disrupt this process, resulting in the distinctive patches seen in individuals with piebaldism.
To diagnose this condition accurately, genetic testing is available, specifically targeting the SNAI2 gene. This test involves analyzing the individual's DNA to identify mutations in the SNAI2 gene that are indicative of piebaldism. It is a critical tool for confirming the diagnosis, understanding the condition's genetic basis, and informing management and genetic counseling.
In the UAE, this specialized genetic test for piebaldism is offered by DNA Labs UAE, a leading provider of genetic testing services in the region. The cost of the SNAI2 gene piebaldism genetic test is 4400 AED. This test is conducted with high precision and accuracy, providing essential information for affected individuals and their families regarding the genetic underpinnings of piebaldism and guiding further medical and personal decision-making processes.
The CARD14 Gene Pityriasis Rubra Pilaris Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CARD14 gene, which are associated with the development of Pityriasis Rubra Pilaris (PRP). PRP is a rare skin disorder characterized by the formation of scaly patches and redness, often leading to widespread inflammation and discomfort. The test aims to provide a genetic confirmation of the condition, enabling more tailored and effective treatment strategies. With a cost of 4400 AED, the test represents a significant step forward in personalized medicine, offering hope to individuals suffering from this challenging condition by facilitating targeted interventions based on their unique genetic makeup.
The USB1 Gene Poikiloderma with Neutropenia Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the USB1 gene, which are known to cause Poikiloderma with Neutropenia (PN). PN is a rare genetic condition characterized by a specific skin rash (poikiloderma), nail abnormalities, and a predisposition to developing neutropenia, a condition involving an abnormally low count of neutrophils, a type of white blood cell crucial for fighting off infections.
This test is particularly important for individuals showing symptoms of PN or those with a family history of the condition, as early and accurate diagnosis can significantly improve management strategies and outcomes. By analyzing the patient's DNA, the test can confirm the presence of the genetic mutations associated with PN, providing essential information for genetic counseling and guiding treatment decisions.
The cost of the USB1 Gene Poikiloderma with Neutropenia Genetic Test at DNA Labs UAE is set at 4400 AED. Given the complexity of the condition and the specialized nature of the test, this price reflects the intricate processes involved in genetic analysis and the expert interpretation of results. Patients considering this test are advised to consult with their healthcare provider to understand its benefits and implications fully.
The MVK Gene Porokeratosis Type 3 Disseminated Superficial Actinic Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the MVK gene associated with Porokeratosis Type 3, also known as Disseminated Superficial Actinic Porokeratosis (DSAP). Porokeratosis is a group of rare skin disorders characterized by the development of abnormal keratinization leading to distinctive ring-like plaques on the skin. DSAP, in particular, is exacerbated by sun exposure and tends to appear in adulthood.
This genetic test plays a crucial role in the accurate diagnosis of DSAP, enabling healthcare providers to tailor specific treatment and management plans for affected individuals. It involves analyzing the patient's DNA to detect mutations in the MVK gene, which have been linked to the condition. Early diagnosis through genetic testing can significantly improve the quality of life for individuals with DSAP by providing insights into the condition's progression, potential complications, and effective preventive measures against excessive sun exposure.
The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results. By choosing DNA Labs UAE for the MVK Gene Porokeratosis Type 3 Disseminated Superficial Actinic Genetic Test, patients can expect a comprehensive evaluation guided by genetic experts in a supportive and informative environment.
The "UROD Gene Porphyria Cutanea Tarda Genetic Test" is a specialized diagnostic examination performed to identify mutations in the UROD gene, which are associated with Porphyria Cutanea Tarda (PCT), the most common type of porphyria. PCT is a condition characterized by sensitivity to sunlight, causing skin blisters, itching, and swelling, primarily on areas of the skin exposed to the sun. It results from reduced activity of the uroporphyrinogen decarboxylase enzyme, crucial in the heme production pathway, leading to the accumulation of porphyrins in the liver and skin.
This genetic test is crucial for confirming a diagnosis of PCT, differentiating it from other types of porphyria, and guiding appropriate management and treatment strategies. It involves analyzing the patient's DNA, extracted from a blood sample, to detect mutations in the UROD gene that are indicative of the disease.
The test is offered at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is set at 4400 AED, reflecting the specialized nature of the testing procedure and the advanced technology used in detecting the genetic mutations associated with Porphyria Cutanea Tarda. By opting for this test at DNA Labs UAE, patients can expect accurate, reliable results, which are essential for the effective management of PCT.
The FECH Gene Protoporphyria Erythropoietic Type 1 Genetic Test is a specialized diagnostic tool used to detect mutations in the FECH gene, which are responsible for Erythropoietic Protoporphyria (EPP) Type 1. EPP is a rare genetic condition characterized by a deficiency in the enzyme ferrochelatase, leading to an accumulation of protoporphyrin in the blood, skin, and liver, causing severe photosensitivity, skin damage, and possibly liver complications. The test involves analyzing the patient's DNA to identify any genetic abnormalities in the FECH gene that may indicate the presence of EPP Type 1.
Conducted at DNA Labs UAE, a leading facility in genetic and genomic testing, this test provides crucial information for the accurate diagnosis and management of EPP. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to perform this advanced genetic analysis. Identifying the specific mutation within the FECH gene can help in understanding the severity of the condition, guiding treatment options, and offering genetic counseling for affected individuals and their families.
The COMP Gene Pseudoachondroplasia Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the COMP gene that are associated with pseudoachondroplasia, a rare genetic disorder. Pseudoachondroplasia is characterized by short stature, abnormal bone growth, and joint abnormalities, which become evident in early childhood. This condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder.
The test involves analyzing the patient's DNA to look for specific mutations in the COMP gene, which plays a crucial role in the development and maintenance of healthy cartilage and bone. By identifying these mutations, the test can confirm a diagnosis of pseudoachondroplasia, enabling appropriate medical management and genetic counseling for affected individuals and their families.
The cost of the COMP Gene Pseudoachondroplasia Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the genetic analysis and the specialized expertise required to interpret the results accurately. For families facing the possibility of pseudoachondroplasia, this test provides a crucial step towards understanding their condition and planning for the future.
The ABCC6 Gene Pseudoxanthoma Elasticum Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ABCC6 gene, which are linked to Pseudoxanthoma Elasticum (PXE). PXE is a rare genetic disorder that causes changes in the skin, eyes, and cardiovascular system, often manifesting through the development of mineralized and fragmented elastic fibers in the body. This leads to a variety of symptoms, including but not limited to, skin lesions, vision problems, and an increased risk of heart disease.
The test is critical for individuals who exhibit symptoms of PXE or have a family history of the condition, as it can confirm a diagnosis, inform treatment strategies, and help in understanding the risk of passing the condition to future generations. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the test involves analyzing the patient's DNA sample to search for specific mutations in the ABCC6 gene that are indicative of PXE.
The cost of the ABCC6 Gene Pseudoxanthoma Elasticum Genetic Test at DNA Labs UAE is set at 4400 AED. This cost reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify the genetic mutations associated with PXE. Patients considering this test are advised to consult with their healthcare providers to understand the implications of the results and the best course of action based on the findings.
The ABCC6 Gene Pseudoxanthoma Elasticum Forme Fruste Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ABCC6 gene. These mutations are associated with Pseudoxanthoma Elasticum (PXE) Forme Fruste, a less severe variant of PXE, a rare genetic disorder that affects the skin, eyes, and cardiovascular system. The condition is characterized by the fragmentation and mineralization of elastic fibers in the connective tissue.
This genetic test is crucial for individuals who exhibit mild symptoms of PXE or have a family history of the condition, as it can confirm the diagnosis and help in managing the disease more effectively. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed to detect any genetic abnormalities in the ABCC6 gene.
The cost of the ABCC6 Gene Pseudoxanthoma Elasticum Forme Fruste Genetic Test at DNA Labs UAE is set at 3200 AED. This investment includes the cost of sample collection, genetic analysis, and a comprehensive report that details the findings. By identifying the genetic basis of the condition, affected individuals can gain insights into their prognosis, potential complications, and inform their healthcare decisions. Additionally, this genetic information can be valuable for family planning and understanding the risk of passing the condition to future generations.
The "GGCX Gene Pseudoxanthoma Elasticum-Like Disorder with Multiple Coagulation Factor Deficiency Genetic Test" is a specialized diagnostic evaluation available at DNA Labs UAE, designed to identify mutations in the GGCX gene. This gene plays a critical role in the carboxylation of glutamic acid residues on various proteins, including those essential for blood clotting and the maintenance of connective tissue integrity. Mutations in the GGCX gene can lead to a rare condition that mimics Pseudoxanthoma Elasticum (PXE), characterized by changes in the skin, eyes, and blood vessels, alongside multiple coagulation factor deficiencies which can lead to abnormal bleeding and bruising.
The test is crucial for individuals displaying symptoms of PXE-like disorder and coagulation problems, as it provides definitive genetic evidence of the condition, enabling tailored clinical management and genetic counseling. The procedure involves a blood sample from which DNA is extracted and analyzed for specific mutations in the GGCX gene.
At DNA Labs UAE, this comprehensive genetic test is offered at a cost of 3200 AED. The test not only aids in the accurate diagnosis of this complex disorder but also helps in understanding the risk of passing it on to future generations, thereby playing a pivotal role in preventive healthcare and personalized medicine.
